Hikma Pharmaceuticals PLC (OTCMKTS:HKMPF – Get Free Report) announced a dividend on Wednesday, February 26th, NASDAQ Dividends reports. Stockholders of record on Friday, March 21st will be given a dividend of 0.48 per share on Thursday, May 1st. The ex-dividend date is Friday, March 21st. This is a positive change from Hikma Pharmaceuticals’s previous dividend of $0.47.
Hikma Pharmaceuticals Stock Performance
OTCMKTS HKMPF opened at $27.17 on Friday. Hikma Pharmaceuticals has a 1-year low of $22.33 and a 1-year high of $28.92. The company has a 50 day moving average of $26.03 and a 200-day moving average of $25.35. The company has a quick ratio of 0.98, a current ratio of 1.66 and a debt-to-equity ratio of 0.46.
Wall Street Analysts Forecast Growth
Separately, Royal Bank of Canada raised Hikma Pharmaceuticals from a “hold” rating to a “moderate buy” rating in a research note on Tuesday, December 10th.
About Hikma Pharmaceuticals
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals.
See Also
- Five stocks we like better than Hikma Pharmaceuticals
- Buy P&G Now, Before It Sets A New All-Time High
- Why Smart Investors Are Watching These 3 Undervalued Stocks
- NYSE Stocks Give Investors a Variety of Quality Options
- 3 Stocks Breaking Out with More Growth Potential Ahead
- Differences Between Momentum Investing and Long Term Investing
- Not Just China: 3 European Stocks Gaining Investor Interest
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
